Insulet (PODD) Non-Current Deferred Tax Liability (2010 - 2012)
Insulet's (PODD) quarterly Non-Current Deferred Tax Liability came in at $700000.0 in Q4 2012, down 22.22% on a YoY basis from $900000.0 in Q1 2012, and down 30.0% quarter-over-quarter from $1.0 million in Q3 2012.
Analysis
Insulet (PODD) Non-Current Deferred Tax Liability (2010 - 2012) Analysis & Trends
Insulet (PODD) has reported Non-Current Deferred Tax Liability for 3 consecutive years, with $700000.0 the latest figure, recorded in Q4 2012.
- For the quarter ending Q4 2012, Non-Current Deferred Tax Liability fell 22.22% year-over-year to $700000.0; the trailing twelve-month figure through Dec 2012 stood at $700000.0 (down 22.22% YoY), and the FY2012 full-year result was $700000.0, down 22.22% from the prior year.
- Non-Current Deferred Tax Liability declined to $700000.0 in Q4 2012 per PODD's latest filing, from $1.0 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $5.5 million in Q2 2011 and bottomed at $700000.0 in Q4 2012.
- Historically, Non-Current Deferred Tax Liability has averaged $1.6 million across 3 years, with a median of $1.0 million in 2012.
- The widest YoY moves for Non-Current Deferred Tax Liability: up 22.22% in 2012, down 81.82% in 2012.
- Over 3 years, Non-Current Deferred Tax Liability stood at $1.4 million in 2010, then slumped by 35.76% to $900000.0 in 2011, then dropped by 22.22% to $700000.0 in 2012.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $700000.0, $1.0 million, and $1.0 million for Q4 2012, Q3 2012, and Q2 2012 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 700,000.00 |
| Sep 30, 2012 | 1.00 Mn |
| Jun 30, 2012 | 1.00 Mn |
| Mar 31, 2012 | 900,000.00 |
| Dec 31, 2011 | 900,000.00 |
| Jun 30, 2011 | 5.50 Mn |
| Dec 31, 2010 | 1.40 Mn |